Trends in the prescription of constipation medications in Japan (fiscal years 2019-2023): A nationwide baseline study prior to the 2023 clinical guidelines
Drug Discoveries & Therapeutics · 30.04.2026 · 20 (2) · 199-204
DOI: 10.5582/ddt.2025.01135 ↗Kurz gefasst
Leitlinie in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 30.04.2026. Verfasst von Hiroyuki Tanaka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan. Hauptthemen laut MEDLINE: Constipation, Laxatives, Practice Patterns, Physicians', Drug Prescriptions. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.
Zitieren
APA
Tanaka, H., & Ishii, T. (2026). Trends in the prescription of constipation medications in Japan (fiscal years 2019-2023): A nationwide baseline study prior to the 2023 clinical guidelines. Drug Discoveries & Therapeutics, 20(2), 199-204. https://doi.org/10.5582/ddt.2025.01135
Vancouver
Tanaka H, Ishii T. Trends in the prescription of constipation medications in Japan (fiscal years 2019-2023): A nationwide baseline study prior to the 2023 clinical guidelines. Drug Discoveries & Therapeutics. 2026;20(2):199-204. doi:10.5582/ddt.2025.01135
BibTeX
@article{Tanaka2026,
author = {Tanaka, Hiroyuki and Ishii, Toshihiro},
title = {Trends in the prescription of constipation medications in Japan (fiscal years 2019-2023): A nationwide baseline study prior to the 2023 clinical guidelines},
journal = {Drug Discoveries & Therapeutics},
year = {2026},
volume = {20},
number = {2},
pages = {199--204},
doi = {10.5582/ddt.2025.01135}
}
EUVIMED